XERIJECT Trademark

Trademark Overview

On Thursday, August 1, 2024, a trademark application was filed for XERIJECT with the United States Patent and Trademark Office. The USPTO has given the XERIJECT trademark a serial number of 98677676. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, November 7, 2024. This trademark is owned by Xeris Pharmaceuticals, Inc.. The XERIJECT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diseases and conditions, namely, alimentary tract, metabolic, oncologic, autoimmune, and nervous system diseases and conditions; pharmaceutical preparations for the treatment of diseases and conditions, namely, anti-invectives to prevent or treat infections, vaccines, antineoplastic pharmaceutical preparations for the treatment of cancer, and immunomodulating pharmaceutical preparations for the treatment of immune system related diseases and disorders
xeriject

General Information

Serial Number98677676
Word MarkXERIJECT
Filing DateThursday, August 1, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, November 7, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 26, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diseases and conditions, namely, alimentary tract, metabolic, oncologic, autoimmune, and nervous system diseases and conditions; pharmaceutical preparations for the treatment of diseases and conditions, namely, anti-invectives to prevent or treat infections, vaccines, antineoplastic pharmaceutical preparations for the treatment of cancer, and immunomodulating pharmaceutical preparations for the treatment of immune system related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 1, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameXeris Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChicago, IL 60601

Trademark Events

Event DateEvent Description
Thursday, August 1, 2024NEW APPLICATION ENTERED
Thursday, August 1, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 2, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, November 2, 2024ASSIGNED TO EXAMINER

Related Keywords

xeriject diseases pharmaceutical treatment preparations conditions system namely antineoplastic vaccines infections